Remote Patient Monitoring Market: Growth, Size, Share, and Trends
Remote Patient Monitoring (RPM) Market by Offering [Software, Device (Wearable, Implants, Handheld)], Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User (Hospital, ASC, Pharma & Biotech) - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The remote patient monitoring market is projected to reach USD 66.33 billion by 2031 from USD 36.29 billion in 2026, at a high CAGR of 12.8% during the forecast period. The development of the remote patient monitoring (RPM) market is fueled by the digitization of healthcare delivery, the adoption of telemedicine in RPM, and the rising prevalence of chronic illness, especially among the aging population. Furthermore, favorable insurance coverage policies, smartphone adoption rates, cloud technology adoption in the healthcare sector, and innovations in artificial intelligence-based monitoring solutions are fueling RPM market growth.
KEY TAKEAWAYS
-
By RegionNorth America accounted for a 53.3% share of the global RPM market in 2025.
-
By ComponentBy component, the software segment is expected to register the highest CAGR of 14.8%.
-
By IndicationBy indication, the cardiology segment accounted for the largest share of the global RPM market in 2024.
-
By End UserBy end user, the patients segment is expected to register the highest CAGR of 13.4%.
-
Competitive LandscapeKoninklijke Philips N.V., OMRON Healthcare, Inc., and Medtronic were identified as some of the star players in the RPM market (global), given their strong market share and product footprint.
-
Competitive LandscapeCompanies such as CareSimple Inc., TimeDoc, Inc., among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The remote patient monitoring (RPM) market is witnessing strong growth, which can be attributed to the digital revolution that has been taking place within the field of patient care, as well as the increasing prevalence of telehealth services along with the growing prevalence of chronic diseases among patients. Furthermore, the growth is also being propelled by the advancement in technology for wearables and mobile health applications.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Consumer impact due to changing business in RPM has been brought about by emerging models of healthcare delivery, as well as increased disruption by digital technology. Hospitals, healthcare providers, payers, and home care providers are the leading users of RPM services in their quest to increase efficiency and improve patient outcomes. Changes in the healthcare landscape are evident in a shift toward a model of delivering continuous, data-driven home-based care to patients.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Expansion of telehealth in remote patient monitoring
-
Transformation of patient care through digital innovation
Level
-
High investments and lack of IT expertise
-
Behavioral barriers and healthcare affordability challenges in remote patient monitoring
Level
-
Emergence of AI & ML
-
Gradual shift toward outpatient care environments
Level
-
Concerns associated with data security
-
Data accessibility issues
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Expansion of telehealth in remote patient monitoring
The expansion of telehealth services across the globe is a driver for RPM by ensuring access to healthcare for patients anytime and anywhere. For instance, telehealth flexibility policies that include home-based supervision and behavioral health services through virtual supervision from CMS have contributed significantly to the adoption of RPM. CMS approved hospital-at-home programs that allowed 345 hospitals across 137 health systems to provide advanced medical care using telehealth. In India, more than 1,600 doctors used the telemedicine platform, Sanjeevani, to connect with over 40,000 patients daily.
Restraint: High investments and lack of IT expertise
The large initial costs involved in deploying RPM systems, along with the scarcity of IT specialists, are some of the primary barriers impeding market growth. In accordance with the HHS OCR data breach portal update issued in February 2026, based on data collected from 2025, network/server breaches made up 61.5% of all reportable breaches, while email compromises were found to account for 24.9%. The inadequately resourced IT landscape thus poses a serious threat to RPM deployment initiatives, while also affecting system integration and maintenance.
Opportunity: Emergence of AI & ML
The advent of artificial intelligence (AI) and machine learning (ML) has brought an opportunity for the remote patient monitoring (RPM) market. With the use of such technologies, one can predict and detect health problems and come up with treatment plans based on real-time patient data. In January 2026, Lord's Mark Industries launched contactless remote patient monitoring (RPM) software, which was implemented at Gauhati Medical College & Hospital in India. It uses artificial intelligence analytics and camera-based monitoring for real-time patient tracking. This demonstrates the growing usage of AI and ML in RPM technology solutions.
Challenge: Concerns associated with data security
Issues related to data security create a challenge to the development of the remote patient monitoring market. The constant flow of data in the form of sensitive health information through interconnected systems creates potential risks of cyber threats, data theft, and breaches. Complying with healthcare data privacy and protection standards, such as HIPAA and GDPR, is yet another hurdle. Security challenges can hinder adoption by affecting patient trust and making healthcare institutions reluctant to implement RPM technologies.
REMOTE PATIENT MONITORING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Virtual Care Management and connected monitoring for chronic conditions (diabetes, COPD, heart disease) | Reduces hospital readmissions, improves outcomes and patient engagement, lowers care costs |
 |
VitalSight home blood pressure and weight monitoring linked to clinicians | Enables early intervention, better hypertension control, and continuous patient oversight |
 |
MyCareLink Smart and Vital Sync for remote monitoring of implantable and hospital-to-home patients | Early detection of complications, reduced hospital stay and improved chronic care management |
 |
Deployment of RPM/virtual-care solutions by combining GE’s inpatient/acute monitoring portfolio with home-based virtual-care and remote-monitoring | Extends hospital-grade monitoring to home, improves capacity, and reduces readmissions |
 |
CardioMEMS HF System for remote monitoring of heart-failure patients | Cuts hospitalizations and mortality, enables proactive treatment, and enhances quality of life |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The remote patient monitoring market's ecosystem comprises entities responsible for the end-to-end workflow of RPM services. The significant stakeholders in this market include telecommunications companies (i.e., network, connectivity, and hardware providers); CT tools and electronics manufacturers (i.e., infrastructure service providers); and service & medical device providers. Healthcare providers (hospitals, health systems, physicians, ACSs, and clinics), Payers, patients/customers, health retailers, senior living/post-acute/hospice centers, start-ups, and governments and regulatory bodies are also stakeholders of this market. Solution and service providers continue to enhance and mature their offerings to increase the value addition. Various hospitals across the world are availing RPM solutions to improve care delivery.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Remote Patient Monitoring (RPM) Market, By Component
In 2025, the device segment held the largest share of the remote patient monitoring (RPM) market. This leadership is driven by the extensive use of sensors, vital signs monitors, implantable medical devices, and connected medical devices that facilitate real-time data collection and monitoring. The devices include the FreeStyle Libre CGM from Abbott, the Dexcom G7, the LINQ II insertable cardiac monitor from Medtronic, the Lux-Dx cardiac monitor from Boston Scientific, the Biosensor BX100 wearable monitor by Philips, and the OMRON connected blood pressure monitors. These devices provide continuous real-time patient monitoring, remote clinician access, and alerts, making them key players in the RPM market.
Remote Patient Monitoring (RPM) Market, By Indication
In 2025, cardiology accounted for the largest share of the remote patient monitoring (RPM) market. The American Heart Association estimates that more than 130 million Americans are predicted to develop any kind of cardiovascular disease by 2035. RPM in the field of cardiology has gained even more momentum owing to the increased use of smart ECG devices, implantable cardiac monitors, cardiac telemonitoring devices, remote monitoring devices for pacemakers, and heart failure management devices. There have also been new product launches, which have further bolstered the market. For example, Boston Scientific has introduced a new LUX-Dx II+ Insertable Cardiac Monitor System in 2025.
Remote Patient Monitoring (RPM) Market, By End User
In 2025, healthcare providers held the largest share of the remote patient monitoring (RPM) market. This is attributed to increased adoption of RPM systems within healthcare facilities to increase patient satisfaction and ensure compliance with the treatment regimen. Connected monitoring systems are increasingly adopted by hospitals, clinics, and home health providers in the management of chronic diseases and monitoring patients who have been discharged. Increased uptake of home hospital services, value-based care systems, favorable reimbursement systems, and the use of telehealth have increased the need for RPM systems. The Centers for Disease Control and Prevention estimates that about 6 out of 10 adults in the US have at least one chronic condition, creating substantial demand for continuous patient monitoring solutions.
REGION
Asia Pacific to be fastest-growing region in global RPM market during forecast period
The Asia Pacific remote patient monitoring (RPM) market is expected to register the highest CAGR during the forecast period, due to the increasing digitization of healthcare, the high prevalence of chronic diseases among patients, and government interventions to encourage telehealth services. Some of the key countries with increasing adoption of connected health devices and applications include China, India, Japan, and South Korea. For example, Abbott disclosed that the FreeStyle Libre CGM system is being used by 8 million patients globally, and some of those regions are the Asia Pacific regions including India, China, Japan, and Australia. ABDM (Ayushman Bharat Digital Mission), launched by the government of India, is helping in growing the adoption of digital health services and connected patient data management. As of February 2025, more than 73.98 crore ABHA (Ayushman Bharat Health Account) ID numbers have been generated. Such initiatives highlight the growth of RPM in Asia-Pacific markets.
REMOTE PATIENT MONITORING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX
In the Remote Patient Monitoring (RPM) market matrix, Abbott (Star) is the leading competitor because of its large market share and wide variety of products, due to its high-performance health connectivity technology, like glucose monitors, cardiac rhythm management systems, and wearables. On the other hand, Teladoc Health Inc. (Emerging Leader) is emerging as a leader in RPM with its growing virtual healthcare network through RPM solutions and telemedicine platforms.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Koninklijke Philips N.V. (Netherlands)
- OMRON Healthcare, Inc. (Japan)
- Medtronic (Ireland)
- GE Healthcare (US)
- Abbott (US)
- Oracle (US)
- Boston Scientific Corporation (US)
- NIHON KOHDEN CORPORATION (Japan)
- Siemens Healthineers AG (Germany)
- Baxter (US)
- Biobeat (Israel)
- Biotronik (Germany)
- VitalConnect (US)
- VivaLNK, Inc (US)
- Clear Arch, Inc (US)
- Optum, Inc (Vivifyhealth) (US)
- Blue Spark Technologies, Inc (US)
- Lightbeam (US)
- Cloud Diagnostics Canada ULC (Canada)
- Teladoc Health, Inc (US)
- Guangdong Transtek Medical Electronics Co., Ltd (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) (Base Year) | USD 31.81 Billion |
| Market Size in 2026 (Value) (Estimated Year) | USD 36.29 Billion |
| Market Forecast in 2031 (Value) (Forecast Year) | USD 66.33 Billion |
| CAGR | CAGR of 12.8% from 2026-2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | USD Billion |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: REMOTE PATIENT MONITORING MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Healthcare Provider | Adoption benchmarking of RPM platforms across hospitals and clinics, Integration analysis with existing EHR and telehealth systems | Optimize clinical workflows and patient engagement strategies, Identify operational efficiencies and cost savings from remote care |
| Device Manufacturer | Competitive assessment of RPM device portfolios (wearables, biosensors, implantables), Technology roadmap for connectivity, AI, and interoperability | Detect product innovation gaps, Highlight opportunities for strategic partnerships with health systems |
| Payer & Insurance Company | Cost-benefit modeling of RPM-enabled care programs, Evaluation of reimbursement trends and payer adoption policies | Identify high-value disease management opportunities, Strengthen policy frameworks for RPM reimbursement |
| Software / Platform Developer | Evaluation of API integration and interoperability across RPM ecosystems, Market mapping of AI-driven analytics platforms | Pinpoint innovation opportunities in predictive analytics, Strengthen differentiation through secure, interoperable architectures |
| Government / Public Health Agency | Assessment of RPM adoption in national telehealth initiatives, Policy mapping for remote care reimbursement frameworks | Support digital health policy development, Identify infrastructure gaps in rural or underserved regions |
| Home Healthcare Service Provider | Operational analysis for scaling home-based RPM programs, Mapping of vendor partnerships for device deployment and support | Enhance quality-of-care delivery in home settings, Strengthen partnerships with payers and hospitals |
RECENT DEVELOPMENTS
- February 2026 : Biotronik partnered with MiCare Path to deliver a comprehensive remote physiologic monitoring (RPM) program for cardiology practices, combining BIOMONITOR IV insertable cardiac monitor devices with MiCare Path RPM devices.
- June 2025 : Philips expanded collaboration efforts for connected patient monitoring through integrated monitoring and consumable solutions with Medtronic, aiming to streamline hospital monitoring workflows and improve RPM-enabled clinical decision-making.
- April 2025 : Medtronic advanced its collaboration with Abbott through the FDA submission of an interoperable insulin pump designed to integrate with Abbott’s advanced CGM platform.
- COLUMN 'A' SHOULD BE IN TEXT FORMAT AND NOT DATE FORMAT :
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
Market Definition
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
Key Stakeholders
- RPM Equipment and devices Manufacturers
- Suppliers and Distributors of RPM Equipment
- RPM software provider
- Healthcare IT Service Providers
- Healthcare Insurance Companies/Payers
- Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Government Bodies/Regulatory Bodies
- Corporate Entities
- Accountable Care Organizations
- RPM Resource Centers
- Research and Consulting Firms
- Medical Research Institutes
- Clinical Departments
Report Objectives
- To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries
Key Questions Addressed by the Report
-
Devices
-
By Function
- Cardiac monitoring devices
- Neurological monitoring devices
- Respiratory monitoring devices
- Blood glucose monitoring devices
- Fetal & neonatal monitoring devices
- Weight monitoring devices
- Multiparameter monitoring devices
- Pulse oximeter devices
- Thermometers
- Other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)
-
By Product type
- Wearable devices
- Implantable devices
- Handheld & portable devices
- Others (stationary devices, and others)
-
By Function
-
Software
-
By deployment model
- On-premise model
- Cloud-based model
-
By transmission type
- Synchronous
- Asynchronous
-
By deployment model
- Services
-
Healthcare Providers
- Hospitals
- Ambulatory surgical centers, ambulatory care centers, and other outpatient settings
- Long-term care & assisted living facilities
- Home healthcare
- Other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)
- Healthcare payers
- Patients
- Pharmaceutical & biotechnology companies
- MedTech companies
- Other end users (employer groups, government organizations, academic institutes, research centers, and others)
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Remote Patient Monitoring (RPM) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Remote Patient Monitoring (RPM) Market
Still Researching the
Remote Patient Monitoring (RPM) Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Chad
Nov, 2021
Can you explain your reasoning around the projection of the $72.8 Billion Mkt for RPM in North America? Thanks.
Alexander
Jun, 2026
After reviewing the Remote Patient Monitoring (RPM) Market report, I gained a much clearer understanding of how reimbursement models and chronic disease management programs are shaping adoption across hospitals and homecare settings..
Patrick
Jun, 2026
I found the breakdown of RPM device integration, cloud connectivity, and patient engagement trends especially useful because it highlighted the operational challenges providers may face during large-scale deployment..
Jack
Jun, 2026
While assessing investment opportunities in digital healthcare, I used this Remote Patient Monitoring (RPM) Market analysis to compare regional growth potential and understand which end-user segments are likely to drive long-term demand..
Amber
Mar, 2022
Which are growth driving factors for the global growth of Remote Patient Monitoring Market?.
Willie
Mar, 2022
What will be the size of the Remote Patient Monitoring Market for the European region?.